Brief Summary
Type:
Leukemias
Study Type:
Treatment
Phase:
I/II
ClinicalTrials.gov Identifier:
NCT02930109
Study #:
STUDY00140819
Start Date:
Dec 20, 2017
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02930109
View Complete Trial Details & Eligibility at ClinicalTrials.gov
